CRT Devices Market | Regional Growth Forecast 2021-2027

CRT Devices Market | Regional Growth Forecast 2021-2027

Cardiac resynchronization therapy (CRT) devices are used to treat heart disorders that are caused due to a slow heart rate. In cardiac resynchronization therapy, several devices are used such as CRT-P and CRT-D which help in maintaining rhythmic heartbeat and enable the heart to pump blood efficiently. The CRT devices’ mechanism is based on cardiac electrophysiology (EP), which is concerned with the analysis, diagnosis, and treatment of the heart’s electrical activities.

A surging number of cardiovascular diseases across the globe are expected to augment the demand for CRT devices in the forthcoming years. As per the World Health Organization estimates, cardiovascular diseases (CVDs) which take 17.9 million lives each year, are the prime cause of death globally among all other diseases.

Request for a sample copy of this report @  

According to a Global Market Insights, Inc., study, global cardiac resynchronization therapy (CRT) devices market size is expected to witness a substantial rise in the upcoming years. Following mentioned are some key factors encouraging the high adoption of CRT devices.

Access to a wide range of CRT devices

Based on the product, the CRT devices industry is categorized into CRT-P and CRT-D. The CRT-P industry share was around US$380 million in 2019 and is anticipated to witness substantial gains in the coming years. The procedure of implanting cardiac resynchronization therapy pacemaker takes only a few hours and the intervention is usually performed by local anesthesia or under short-term sedation. Consistent rise in healthcare spending in emerging economies will bolster the market forecast.

High adoption of CRT pacemakers

CRT-P is comprised of three leads that connect the pacemaker to the right atria and both lower ventricles. To treat slow heart rhythms, the CTR pacemaker delivers small electrical impulses to maintain rhythmic contraction of both the ventricles, so that the heart pumps efficiently. These devices help heart patients to maintain a healthy and normal heartbeat and the body to circulate the right amount of blood it needs.

Prevalence of heart disease among younger generation

As per the age, the cardiac resynchronization therapy (CRT) devices industry is categorized into below 44 years, 45-64 years, 65-84 years, and above 85 years. The industry share from below 44 years patient segment is predicted to rise at a significant growth rate of 7.1% in the forthcoming years. The growing prevalence of obesity among this age group due to sedentary lifestyles and high consumption of junk food, alcohol, tobacco, and others causes a high percentage of heart disorders.  

Request for customization @

Preference for heart treatment in hospitals

With respect to end-use, the industry is bifurcated into ambulatory surgical centers, hospitals, and cardiac care centers. The hospital segment accounted for US$950 million in 2019 of the total market share, and is forecasted to grow significantly in the coming years. The availability of highly skilled professionals such as general practitioners, heart failure specialists, electro-physiologists, and cardiologists, along with greater infrastructure as compared to other healthcare facilities primarily attracts patients to avail heart treatment in hospitals.

Surging incidences of myocardial infarction in Latin America

Latin America cardiac resynchronization therapy devices industry was worth around US$60 million in 2019 and is expected to expand owing to the growing prevalence of cardiovascular disease in the region. As per the INTERHEART (a study of risk factors for first myocardial infarctions across the globe) data, a high percentage of myocardial infarction in Latin America is due to dyslipidemia, abdominal obesity, and smoking.

Cardiovascular diseases (CVD) in the Americas is the leading causes of death which accounts for 33.7% of the total mortality rates in the region. The surging number of CVD along with enhancing healthcare infrastructure is predicted to positively influence industry expansion in the nation.

Partial Chapter of the Table of Content

Chapter 2.   Executive Summary

2.1. Cardiac resynchronization therapy devices industry 3600 synopsis, 2015 - 2026

2.1.1.  Business trends

2.1.2.  Product trends

2.1.3.  Age trends

2.1.4.  End-use trends

2.1.5.  Regional trends

Chapter 3.   Cardiac Resynchronization Therapy Devices Industry Insights

3.1. Industry segmentation

3.2. Industry landscape, 2015 - 2026

3.3. Industry impact forces

3.3.1.  Growth drivers Growing incidence of cardiovascular disorders across the globe Increasing geriatric population across the world Technological advancements in cardiac resynchronization therapy devices Favorable reimbursement scenario

3.3.2.  Industry pitfalls & challenges High cost of CRT devices Stringent regulatory scenario

3.4. Growth potential analysis

3.4.1. By product

3.4.2. By age

3.4.3. By end-use

3.5. Regulatory landscape

3.5.1.  U.S.

3.5.2.  Europe

3.6. Porter's analysis

3.7. Competitive landscape, 2018

3.7.1.  Competitive matrix analysis, 2018

3.8. PESTEL analysis

Browse complete Table of Contents (ToC) of this research report @